Remedium Lifecare Share Price
Small Cap | Service | BSE: 539561
₹3.86 
-0.07 (-1.78 %)
Last Updated: 11 Feb 2025 03:55 PM
BEARISH
Overview
Open (₹) 3.86
High (₹) 3.86
Low (₹) 3.86
Prev. Close (₹) 3.93
Volume 15,35,500
VWAP (₹) 4.01
ROCE (%) 126.46
Industry P/E 40.3
TTM P/E 8.39
P/B Ratio 0.91
Market Cap (₹) Cr.155.64
Dividend Yield (%)--
EPS (₹) 3.25
ROE76.29%
Sales Growth (%) 692.75
Profit Growth (%)503.2
Day Range
3.863.86
52 Week Range
4.0138.25
Historical Returns
Returns (6M)
-58.36 %
Returns (1Y)
-82.94 %
Returns (3Y)
211.29 %
Returns (5Y)
1931.58 %
Returns (6M)
-58.36 %
Returns (1Y)
-82.94 %
Returns (3Y)
211.29 %
Returns (5Y)
1931.58 %
SWOT Analysis
Technicals
Technical Rating
BEARISHRSI N/A
MFI N/A
ATR 0.09
Commodity Channel Index -119.38
ROC125 -66.72
ROC21 -31.34
Williams %R -100
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 | 4.01 |
| Week Ago | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 | 4.5 |
| Month Ago | 5.58 | 5.58 | 5.59 | 5.57 | 5.57 | 5.56 | 5.56 |
EMA & SMA
3.86
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 4.22
9 Day 4.41
10 Day 4.45
12 Day 4.59
14 Day 4.64
20 Day 4.93
26 Day 4.98
50 Day 5.17
100 Day 6.33
200 Day 11.61
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| CHIRAG NARENDRABHAI MODH | bulk | Sell | 07 Feb, 2025 | ₹4.01 | 24,30,153 | BSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 21 Aug, 2024 | ₹9.71 | 21,80,530 | BSE |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 20 Aug, 2024 | ₹8.37 | 26,80,530 | BSE |
| TRAPAL TRADING PRIVATE LIMITED | bulk | Sell | 31 Jul, 2024 | ₹14.3 | 22,89,075 | BSE |
| TRAPAL TRADING PRIVATE LIMITED | bulk | Buy | 31 Jul, 2024 | ₹14.15 | 27,41,844 | BSE |
| NISHCHAYA TRADINGS PRIVATE LIMITED | bulk | Sell | 18 Jul, 2024 | ₹19.22 | 9,60,000 | BSE |
| NISHCHAYA TRADINGS PRIVATE LIMITED | bulk | Buy | 18 Jul, 2024 | ₹19.04 | 9,05,494 | BSE |
| NISHCHAYA TRADINGS PRIVATE LIMITED | bulk | Sell | 16 Jul, 2024 | ₹16.19 | 5,72,717 | BSE |
| ALOK ASHOK TIWARI | bulk | Sell | 16 Jul, 2024 | ₹16.23 | 6,06,978 | BSE |
| NISHCHAYA TRADINGS PRIVATE LIMITED | bulk | Buy | 16 Jul, 2024 | ₹15.99 | 6,52,878 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 15 Jun, 2022 | Mr. Mukesh Naresh | Acquisition | ₹137.06 | 7,300 | BSE |
| 27 Aug, 2021 | Mr. Mukesh Kumar Naresh | Acquisition | ₹130 | 3,800 | BSE |
| 19 Aug, 2021 | Mr. Mukesh Kumar Naresh | Acquisition | ₹130.04 | 3,800 | BSE |
| 16 Aug, 2021 | Mr. Mukesh Kumar Naresh | Acquisition | ₹128 | 3,800 | BSE |
| 04 Aug, 2021 | Mr. Mukesh Kumar Naresh | Acquisition | ₹129.05007072135786 | 3,535 | BSE |
| 30 Jul, 2021 | Mr. Mukesh Kumar Naresh | Acquisition | ₹128 | 3,735 | BSE |
| 19 Jul, 2021 | Mr. Mukesh Kumar Naresh | Acquisition | ₹127 | 3,835 | BSE |
| 02 Jul, 2021 | Mr. Siddharth Shah | Disposal | ₹102.37268849752338 | 2,18,040 | BSE |
| 01 Jul, 2021 | Mr. Siddharth Shah | Disposal | ₹102.25 | 45,580 | BSE |
| 17 Jun, 2021 | Mr. Siddharth Shah | Disposal | ₹100.45867 | 1,00,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 27 May, 2024 | Bonus issue of equity shares in the ratio of 3:1 of Rs. 10/-. | 05 Jul, 2024 | 06 Jul, 2024 |
| 08 Jan, 2024 | Stock split from Rs. 5/- to Re. 1/-.. | 23 Feb, 2024 | 23 Feb, 2024 |
| 23 Jun, 2023 | Bonus issue of equity shares in the ratio of 9:5 of Rs. 10/-. | 28 Jul, 2023 | 29 Jul, 2023 |
| 23 Jun, 2023 | Stock split from Rs. 10/- to Rs. 5/-. | 01 Sept, 2023 | 01 Sept, 2023 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 08 Feb, 2025 | BSE India | Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve 1) Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 31st December, 2024. 2) Any Other Business With The Permission Of The Chair. |
| 25 Jan, 2025 | BSE India | Outcome of Board Meeting for approval of Draft Letter of Offer in regards to the Rights Issue of Equity Shares. |
| 24 Jan, 2025 | BSE India | Postal Ballot- Scrutinizer''s Report for Postal Ballot Notice dated December 23, 2024. |
| 24 Jan, 2025 | BSE India | Postal Ballot Result for Postal Ballot Notice dated December 23, 2024 seeking approval of the members for the resolution |
| 22 Jan, 2025 | BSE India | In terms of Regulation 30 of SEBI (Listing Obligation Disclosure Requirement) Regulations, 2015 and in addition to disclosure regarding appointment of Director dated January 22nd 2025, we wish to inform that the Board considered and approved Reconstitution of the Committees |
| 22 Jan, 2025 | BSE India | Intimation for appointment of Ms. Shamim Adil Michal as an Additional (Non-Executive Independent) Director of the Company |
| 22 Jan, 2025 | BSE India | Outcome of Board Meeting held on Wednesday, January 22, 2025 for\r\n\r\n1) Right issue of shares\r\n2) Increase in authorised share capital\r\n3) Appointment of Additional Independent Director\r\n |
| 17 Jan, 2025 | BSE India | Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 ,inter alia, to consider and approve raising funds by way of issue of fresh equity shares through Right Issue basis along-with other matter, if any, as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required.\r\n2) Any other business with the permission of the Chair. |
| 07 Jan, 2025 | BSE India | We write to you in reference to recent media reports claiming that Remedium Lifecare Limited has received an order worth ?8,500 crore from Eli Lilly and Company. The reports further suggest that this order marks a significant milestone for our company and the Indian pharmaceutical sector.\r\nWe would like to categorically state that these reports are entirely speculative and unfounded. Remedium Lifecare Limited has not entered into any such agreement or received any orders from Eli Lilly and Company, as mentioned in the media.\r\nAs a responsible corporate entity, we remain committed to providing accurate and timely information to the exchange and our stakeholders in accordance with the applicable regulations. Should there be any material developments or agreements that require disclosure, we will notify the exchange in due course.\r\nWe kindly request BSE to take note of this clarification and advise investors and stakeholders to refrain from relying on unverified media reports.\r\n |
| 04 Jan, 2025 | BSE India | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('Listing Regulations'), we wish to inform you about the following changes in composition of the Board:\r\n(a) Ms. Seema Sanei (DIN: 10549952), has tendered her resignation as an Independent Director of the Company, with effect from closure of business hours on 03rd January, 2025, citing pre-occupation and other personal commitments. Consequently, She shall also cease to be a Chairman of the Nomination and Remuneration Committee and Risk Management Committee of the Company.\r\n(b) Mr. Pratik Shah (DIN: 06809235), has tendered his resignation as the Independent Director of the Company, with effect from closure of business hours on 03rd January, 2025 citing pre-occupation and other personal commitments. Consequently, he shall also cease to be Member of the Stakeholders Relationship Committee of the Company. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Others | Inter-alia, to consider 1. Raising funds by way of issue of fresh equity shares through Right Issue basis along-with other matter. 2. Other business matters. | 20 Jan, 2025 | 22 Jan, 2025 |
| Quarterly Results | -- | 12 Nov, 2024 | 14 Nov, 2024 |
| Quarterly Results | (Revised) | 08 Aug, 2024 | 14 Aug, 2024 |
| Quarterly Results | -- | 08 Aug, 2024 | 08 Aug, 2024 |
| Increase in Authorised Capital | -- | 19 Jul, 2024 | 20 Jul, 2024 |
| Others | -- | 03 Jul, 2024 | 08 Jul, 2024 |
| Audited Results & Bonus issue | (Revised) | 10 May, 2024 | 27 May, 2024 |
| Audited Results & Bonus issue | -- | 10 May, 2024 | 10 May, 2024 |
| Quarterly Results | -- | 07 Feb, 2024 | 14 Feb, 2024 |
| Stock Split | -- | 03 Jan, 2024 | 08 Jan, 2024 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jul, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Remedium Lifecare
Remedium Lifecare is a Public Limited Listed company incorporated on 19/02/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1988PLC343805 and registration number is 008009. Currently company belongs to the Industry of Trading & Distributors. Company’s Total Operating Revenue is Rs. 4041.71 Cr. and Equity Capital is Rs. 10.08 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1988
Managing Director
-- --
NSE Symbol
--
Remedium Lifecare Management
| Name | Designation |
|---|---|
| Mr. Adarsh Munjal | Whole Time Director |
| Mr. Hanosh Santok | Non Executive Director |
| Ms. Maneesha Naresh | Independent Director |
| Ms. Trupti Bolke | Independent Director |
| Mr. Pratik Shah | Independent Director |
| Ms. Seema Sanei | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Adani Enter | ₹2,78,151.78 | ₹2,321.75  ₹2,290.80(1.35%) | ₹2,030.000 - ₹3,743.000 |
| MMTC | ₹10,980.00 | ₹63.80  ₹65.90(-3.19%) | ₹58.830 - ₹131.880 |
| Shree Global | ₹5,975.18 | ₹48.38 ₹50.39(-3.99%) | ₹27.300 - ₹54.600 |
| MSTC Ltd | ₹4,742.14 | ₹583.50 ₹560.55(4.09%) | ₹558.250 - ₹1,165.000 |
| KansalFibres | ₹1,766.92 | ₹7.37 ₹7.02(4.99%) | ₹3.595 - ₹44.660 |
FAQs on Remedium Lifecare
What is the share price of Remedium Lifecare?
The share price of Remedium Lifecare on 11 Feb, 2025 is ₹ 3.86.
What is 52W high and 52W low share price of Remedium Lifecare?
The highest and lowest 52W share prices of Remedium Lifecare are ₹ 38.250 and ₹ 4.940
What is the market cap of Remedium Lifecare?
The market capitalization of Remedium Lifecare as of 11 Feb, 2025 is ₹ 155.64 Crores
What is the P/E ratio of Remedium Lifecare?
The current P/E ratio of Remedium Lifecare as of 11 Feb, 2025 is 40.3
What is the PB ratio of Remedium Lifecare?
The PB ratio of Remedium Lifecare as of 11 Feb, 2025 is 0.91
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)